Ali Behbahani Insider Trading $ADAP Adaptimmune Therapeutics PLC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).

Ali Behbahani in Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 19,500,000 shares
Current Value: $88,335,000
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 19,500,000
Shares Sold: 0
Share Difference: +19,500,000
Value Difference: -$25,000,650

Latest Insider Trading Transactions of Ali Behbahani in Adaptimmune Therapeutics PLC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2020ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA1.67184,258307,711184,258
Jan 28 2020ADAPAdaptimmune Therap ...Behbahani AliDirectorBuyP0.677,500,0005,000,25019,500,00012 M to 19.5 M (+62.50 %)
Jul 03 2019ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA0.61234,407142,988234,407
Sep 10 2018ADAPAdaptimmune Therap ...Behbahani AliDirectorBuyP1.6712,000,00020,000,40012,000,0000 to 12 M
Jun 26 2018ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA2.18154,809337,484154,809
Jul 03 2017ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA0.75220,788165,591220,788
Aug 12 2016ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA1.27184,562234,394184,562

Page:   1